•  
  •  
  •  
  •  

2025-12-24 00:59:10

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • TAKE Solutions Outlines a Strategic Plan to Build an Advanced AI-Driven Diagnostic & Preventive Care Platform
  • Monte Carlo Fashions Ltd receives LOA from MPUVNL for Solar PV Power Plants
  • Zydus partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
  • ITCONS E-Solutions Ltd awarded contract worth Rs. 1.59 crore
  • CDG PETCHEM Ltd secures strategic last-mile transportation contracts with APL Logistics Vascor Automotive Private Limited

Keywords Selected:  TorrentPharmaceuticals

Stock Report

  • Torrent Pharmaceuticals Ltd to invest in Torrent Urja 27 Pvt Ltd
  • Torrent Pharmaceuticals Ltd consolidated Q1FY26 PAT climbs to Rs. 548 crores
  • Torrent Pharma to acquire controlling stake in J. B. Chemicals & Pharmaceuticals from KKR
  • Torrent Pharmaceuticals Ltd Q3FY25 consolidated profit climbs to Rs. 503 crores
  • Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
  • Torrent Pharmaceuticals Ltd refutes claims of Shelcal 500 allegedly failing CDSCO quality test
  • Torrent Pharmaceuticals Ltd receives Form 483 from USFDA for Formulation Facility
  • Torrent Pharmaceuticals Ltd reports higher consolidated Q1FY25 PAT of Rs. 457 crores
  • Torrent Pharmaceuticals Ltd gets Form 483 with 5 observations for Indrad facility
  • Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India
  • Torrent Pharmaceuticals Ltd redeems part of NCDs
  • Torrent Pharmaceuticals Ltd gets Form 483 from USFDA after Pre-Approval Inspection for Bileshwarpura facility
  • Torrent Pharmaceuticals Ltd's Dahej facility gets EIR from USFDA
  • Torrent Pharmaceuticals Ltd Q1 FY2023-24 consolidated PAT rises to Rs. 378 crores
  • USFDA Pre-Approval Inspection of Oral Oncology Manufacturing facility, Gujarat
  • Torrent Pharmaceuticals Ltd declares interim dividend of Rs. 14
  • Torrent Pharmaceuticals Ltd Q3FY23 consolidated PAT slips QoQ to Rs. 283 crores
  • Torrent Pharmaceuticals Ltd enters into co-marketing partnership with Boehringer Ingelheim India Pvt Ltd
  • Torrent Pharmaceuticals Ltd reports Rs. 312 crores consolidated profit in Q2 FY23
  • Torrent Pharma to acquire Curatio Healthcare for Rs. 2000 crores
  • Torrent Pharmaceuticals Ltd posts Rs. 354 crores consolidated PAT in Q1FY23
  • Torrent Pharma acquires 4 Brands from Dr. Reddy's Laboratories
  • Torrent Pharmaceuticals Ltd recommends 1:1 bonus issue
  • Torrent Pharmaceuticals Ltd recommends final dividend of Rs. 23

Latest Post

  • TAKE Solutions Outlines a Strategic Plan to Build an Advanced AI-Driven Diagnostic & Preventive Care Platform
  • Monte Carlo Fashions Ltd receives LOA from MPUVNL for Solar PV Power Plants
  • Zydus partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
  • ITCONS E-Solutions Ltd awarded contract worth Rs. 1.59 crore
  • CDG PETCHEM Ltd secures strategic last-mile transportation contracts with APL Logistics Vascor Automotive Private Limited


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024